| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 1,972,000 | 1,733,000 | 2,722,000 | 2,319,000 | | Cost of Revenue | 1,218,000 | 1,108,000 | 1,621,000 | 1,411,000 | | | Gross Profit | 754,000 | 625,000 | 1,101,000 | 908,000 | | | Operating Expenses | | Research Development | 301,000 | 341,000 | 335,000 | 377,000 | | Selling General and Administrative | 437,000 | 528,000 | 478,000 | 522,000 | | Non Recurring | (11,000) | 21,000 | 1,333,000 | 1,186,000 | | Others | 11,000 | 10,000 | 12,000 | 11,000 | | | | Total Operating Expenses | 738,000 | 900,000 | 2,158,000 | 2,096,000 | | | | Operating Income or Loss | 16,000 | (275,000) | (1,057,000) | (1,188,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (144,000) | (122,000) | (28,000) | 6,000 | | Earnings Before Interest And Taxes | (180,000) | (345,000) | (1,085,000) | (1,182,000) | | Interest Expense | 74,000 | 77,000 | 85,000 | 81,000 | | Income Before Tax | (254,000) | (422,000) | (1,170,000) | (1,263,000) | | Income Tax Expense | 62,000 | 7,000 | 967,000 | 2,129,000 | | Minority Interest | (11,000) | (26,000) | 2,000 | (21,000) | | | | Net Income From Continuing Ops | (274,000) | (507,000) | (2,135,000) | (3,413,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (274,000) | (507,000) | (2,135,000) | (3,413,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($274,000) | ($507,000) | ($2,135,000) | ($3,413,000) |
|
0.83% Nasdaq 
0.003 (9.68%) 
Income Statement
